$CBLL

Manni Joseph S. sold $25K of CBLL

Manni Joseph S. (Chief Revenue Officer) sold 1,378 shares of Ceribell, Inc. (CBLL) at $18.00 on 2026-05-21.

Original reporting
SEC EDGAR · Manni Joseph S.
Published May 26, 2026, 8:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CBLL
Neutral
medium confidence
Mentioned
$CBLL
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBLLNeutralMed
01

Why it matters

This is a disclosure of an open-market sale (code S) of CBLL shares; it may affect short-term sentiment but does not provide new operational/financial information.

02

Market read

Traders may monitor for follow-on insider selling or correlate with upcoming company catalysts, but the filing alone is not a fundamental driver.

03

What to watch

No 10b5-1 plan is noted, but the filing does not explain rationale; also, one sale is not a trend without additional subsequent insider transactions.

Relevance 7/10Timing: New Form 4 filed 2026-05-26; any reaction is likely immediate and short-lived unless corroborated by other signals.

Background

SEC Form 4 insider transaction disclosure for Ceribell, Inc. (CBLL) by its Chief Revenue Officer, filed via EDGAR.

Company-level read

Ticker impact

$CBLLNeutralMedium confidence
Context

Ceribell insider Chief Revenue Officer sold 1,378 shares in an open-market transaction priced at $18.00 on 2026-05-21.

Expected impact

Near-term: limited downside bias; any move likely fades unless followed by additional insider selling or operating news.

Evidence & confidence

Insider sales are common and the disclosed size ($24.8K) is small relative to typical market moves; absence of a 10b5-1 plan raises attention but does not establish bearish fundamentals.

Market effects

For biotech/diagnostics, insider sales can influence retail sentiment but rarely reset sector expectations absent clinical/regulatory updates.

No clear regional spillover; this is company-specific insider activity.

Limited global relevance; disclosure is US SEC and does not indicate international operational changes.

Counterpoint

The sale could be routine liquidity/portfolio management rather than a view on business prospects, especially given the modest dollar value.

Key entities

  • Ceribell, Inc.

    CBLL insider transaction disclosed on SEC Form 4; officer sold 1,378 shares at $18.00.

  • Manni Joseph S.

    Chief Revenue Officer who executed the open-market sale; holdings after transaction: 56,291 shares.

Related articles